Genome Damage and Stability Centre, School of Life Sciences, Falmer, Brighton, BN1 9RQ, United Kingdom; Department of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20, Prague, 4, Czech Republic.
DNA Repair (Amst). 2019 Sep;81:102664. doi: 10.1016/j.dnarep.2019.102664. Epub 2019 Jul 8.
The human gene that encodes XRCC1 was cloned nearly thirty years ago but experimental analysis of this fascinating protein is still unveiling new insights into the DNA damage response. XRCC1 is a molecular scaffold protein that interacts with multiple enzymatic components of DNA single-strand break repair (SSBR) including DNA kinase, DNA phosphatase, DNA polymerase, DNA deadenylase, and DNA ligase activities that collectively are capable of accelerating the repair of a broad range of DNA single-strand breaks (SSBs). Arguably the most exciting aspect of XRCC1 function that has emerged in the last few years is its intimate relationship with PARP1 activity and critical role in preventing hereditary neurodegenerative disease. Here, I provide an update on our current understanding of XRCC1, and on the impact of hereditary mutations in this protein and its protein partners on human disease.
将近三十年前,人类 XRCC1 基因被克隆出来,但对这种迷人蛋白质的实验分析仍在不断揭示 DNA 损伤反应的新见解。XRCC1 是一种分子支架蛋白,与 DNA 单链断裂修复 (SSBR) 的多个酶促成分相互作用,包括 DNA 激酶、DNA 磷酸酶、DNA 聚合酶、DNA 脱腺苷酶和 DNA 连接酶活性,这些酶共同能够加速广泛的 DNA 单链断裂 (SSBs) 的修复。可以说,XRCC1 功能中最令人兴奋的方面是它与 PARP1 活性的密切关系及其在预防遗传性神经退行性疾病中的关键作用。在这里,我提供了对我们目前对 XRCC1 的理解的更新,以及该蛋白及其蛋白伴侣中的遗传突变对人类疾病的影响。